These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 16825808)

  • 1. Is HCl duloxetine effective in the management of urinary stress incontinence after radical prostatectomy?
    Zahariou A; Papaioannou P; Kalogirou G
    Urol Int; 2006; 77(1):9-12. PubMed ID: 16825808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation among maximal urethral closure pressure, retrograde leak point pressure, and abdominal leak point pressure in men with postprostatectomy stress incontinence.
    Comiter CV; Sullivan MP; Yalla SV
    Urology; 2003 Jul; 62(1):75-8. PubMed ID: 12837426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retrograde leak point pressure for evaluating postradical prostatectomy incontinence.
    Comiter CV; Sullivan MP; Yalla SV
    Urology; 1997 Feb; 49(2):231-6. PubMed ID: 9037285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprostatectomy established stress urinary incontinence treated with duloxetine.
    Collado Serra A; Rubio-Briones J; Puyol Payás M; Iborra Juan I; Ramón-Borja JC; Solsona Narbón E
    Urology; 2011 Aug; 78(2):261-6. PubMed ID: 21601255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary results on the off-label use of duloxetine for the treatment of stress incontinence after radical prostatectomy or cystectomy.
    Schlenker B; Gratzke C; Reich O; Schorsch I; Seitz M; Stief CG
    Eur Urol; 2006 Jun; 49(6):1075-8. PubMed ID: 16481094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of duloxetine on urethral function and sphincter morphology.
    Athanasiou S; Chaliha C; Digesu GA; Sotiropoulou M; Georgoulias N; Khullar V; Antsaklis A
    Int Urogynecol J Pelvic Floor Dysfunct; 2007 Jul; 18(7):763-7. PubMed ID: 17061027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic evaluation before and immediately after robot-assisted radical prostatectomy.
    Kadono Y; Ueno S; Yaegashi H; Ofude M; Izumi K; Maeda Y; Mizokami A; Miwa S; Miyagi T; Namiki M
    Urology; 2014 Jul; 84(1):106-11. PubMed ID: 24976226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence.
    Twiss C; Fleischmann N; Nitti VW
    Neurourol Urodyn; 2005; 24(3):207-10. PubMed ID: 15791628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of duloxetine for stress incontinence after prostatectomy.
    Hotston MR; Hurley K; Patel S; Persad R
    BJU Int; 2006 Oct; 98(4):916-7. PubMed ID: 16978296
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conservative treatment of male stress incontinence].
    Buse S; Reitz A; Haferkamp A; Hohenfellner M
    Urologe A; 2007 Mar; 46(3):240-3. PubMed ID: 17294152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of Duloxetine in the treatment of male stress urinary incontinence.
    Fink KG; Huber J; Würnschimmel E; Schmeller NT
    Wien Med Wochenschr; 2008; 158(3-4):116-8. PubMed ID: 18330528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The correlation between retrograde leak point pressure and 24-hour pad weight.
    Solomon E; Kass-Iliyya A; Malde S; Kirkham APS; Greenwell TJ; Ockrim JL
    Neurourol Urodyn; 2017 Apr; 36(4):1119-1123. PubMed ID: 27376718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of stress urinary incontinence and intrinsic sphincter deficiency in patients with stage IV pelvic organ prolapse.
    Muñiz KS; Pilkinton M; Winkler HA; Shalom DF
    J Obstet Gynaecol Res; 2021 Feb; 47(2):640-644. PubMed ID: 33205578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine for mild to moderate postprostatectomy incontinence: preliminary results of a randomised, placebo-controlled trial.
    Cornu JN; Merlet B; Ciofu C; Mouly S; Peyrat L; Sèbe P; Yiou R; Vallancien G; Debrix I; Laribi K; Cussenot O; Haab F
    Eur Urol; 2011 Jan; 59(1):148-54. PubMed ID: 21030144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Place of duloxetine in the treatment of stress urinary incontinence].
    Rouprêt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Duloxetine for Postprostatectomy Stress Urinary Incontinence: A Systematic Review.
    Kotecha P; Sahai A; Malde S
    Eur Urol Focus; 2021 May; 7(3):618-628. PubMed ID: 32605820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological treatment for stress urinary incontinence in prostate cancer].
    Puyol M; Collado A
    Arch Esp Urol; 2009 Dec; 62(10):882-8. PubMed ID: 20068265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.